Dana Lueck-Mammen
Lawyers

Associate in our Corporate practice, based in Northern California.
Experience highlights
Recent Representations
- Aligos Therapeutics $92 million private placement
- Marvell Technology $1 billion senior notes offering
- Natera $250 million follow-on offering
- NGM Biopharmaceuticals $100 million at-the-market offering
- Weyerhaeuser $750 million notes offering
- HilleVax $200 million IPO
- Credo Technology Group $200 million IPO
- NVIDIA $5 billion senior notes offering
- Globe Life $325 million junior subordinated debt offering
- Connect Biopharma $219.9 million IPO
- Illumina $1 billion notes offering
- Enphase Energy $1.15 billion green convertible senior notes offering
- Sunrun $400 million convertible senior notes offering
- Poshmark $318.8 million IPO
- Zynga $874.5 million convertible senior notes offering
- Turning Point Therapeutics $460 million stock offering
Education
J.D., UC Berkeley School of Law
- Order of the Coif
- Articles Editor, Berkeley Business Law Journal
- Member, Berkeley Journal of Entertainment & Sports Law
B.A., English and French, Santa Clara University
- cum laude
Professional history
- Davis Polk since 2019
Qualifications and admissions
- State of California